Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone
- 24 September 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 184, 80-89
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001070)
This publication has 25 references indexed in Scilit:
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Prognosis on Chronic Dobutamine or Milrinone Infusions for Stage D Heart FailureCirculation: Heart Failure, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Inotropes and VasopressorsCirculation, 2008
- Chronic inotropic therapy in end-stage heart failureAmerican Heart Journal, 2006
- Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic TherapyCirculation, 2004
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Long-term benefit of dobutamine in patients with congestive cardiomyopathyAmerican Heart Journal, 1980
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978